Recruiting Myelodysplastic Syndromes Studies in Miami
A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
The purpose of this study is to evaluate the effects of KER-050 on anemia in patients with very low, low or intermediate risk MDS....
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)...
About Myelodysplastic Syndromes Clinical Trials in Miami
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 2 myelodysplastic syndromes clinical trials recruiting participants in Miami, FLORIDA. These studies are seeking a combined 226 participants. Research is being sponsored by Takeda, Rigel Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in Miami — FAQ
Are there myelodysplastic syndromes clinical trials in Miami?
Yes, there are 2 myelodysplastic syndromes clinical trials currently recruiting in Miami, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated March 2, 2026 from ClinicalTrials.gov